Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
140 participants
INTERVENTIONAL
2011-12-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Continuous use of sedatives and analgesics (commonly called "sedation") will be stopped upon enrolment.
* Ventilator asynchrony in Volume assist Controlled Ventilation (VCV) will be treated by switching to Pressure Support Ventilation (PSV) or adjusting setting of VCV.
* Pain, anxiety and agitation will be treated by priority setting of the mechanical ventilator aimed to deliver the most comfortable ventilator support and secondly by adding analgesics and/or psychoactive drugs without inducing a coma state.- Persistent ventilator asynchrony or persistent agitation will be treated by 6-hours continuous sedation periods.
* Extubation will be performed according to criteria defined by the national consensus on mechanical ventilation weaning, which are based on a daily spontaneous breathing trial in the absence of any sedation.
Control group (standard practices):
* Continuous use of sedatives and analgesics (commonly called "sedation") will be daily stopped according to criteria defined by the national consensus on sedation for ICU patients.- During the period before the interruption of sedation, ventilator asynchrony in VCV will be treated by increasing the depth of sedation and then the dose of opioids.
* During the period before the interruption of sedation, pain, anxiety and agitation will be treated by a priority adjustment of sedation according to the nurse driven protocol recommended by the national consensus on sedation for ICU patients.- During the period after the interruption of sedation, ventilator asynchrony will be treated by switching to the PSV mode. In case of return to VCV, asynchrony will be treated by restart of sedation.
* During the period after the interruption of sedation, pain, anxiety and agitation will be treated as for the intervention group.
* Extubation will be performed according to criteria defined by the national consensus on mechanical ventilation weaning, which are based on a daily spontaneous breathing trial in the absence of any sedation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
S.O.S.-V
Therapy strategy
Sedation \& mechanical ventilation
Standard
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapy strategy
Sedation \& mechanical ventilation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 1 organ dysfunction according to SOFA score
* Non paralyzed because of neuromuscular blocking agents
* Body temperature \> or equal 36°CAge \> or equal 18
* Surrogate decision maker's consent
Exclusion Criteria
* Continuous mechanical ventilation for 24-hours or longer
* Hospitalisation in ICU for 7-days or longer
* Severe ARDS (Acrasis study criteria, New England J Med 2011)
* Neurological injury
* Active toxicomania
* Reduction or cessation of active treatment
* Patient under tutelage
* Pregnancy
* No French health insurance
* Enrollment in another study on sedation or mechanical ventilation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerald GC Chanques, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UH, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology & Critical Care, Estaing University Hospital
Clermont-Ferrand, , France
Department of Anesthesiology & Critical Care, St Eloi University Hospital
Montpellier, , France
Department of Anesthesiology & Critical Care, Caremeau University Hospita
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chanques G, Conseil M, Roger C, Constantin JM, Prades A, Carr J, Muller L, Jung B, Belafia F, Cisse M, Delay JM, de Jong A, Lefrant JY, Futier E, Mercier G, Molinari N, Jaber S; SOS-Ventilation study investigators. Immediate interruption of sedation compared with usual sedation care in critically ill postoperative patients (SOS-Ventilation): a randomised, parallel-group clinical trial. Lancet Respir Med. 2017 Oct;5(10):795-805. doi: 10.1016/S2213-2600(17)30304-1. Epub 2017 Sep 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8667
Identifier Type: -
Identifier Source: org_study_id